# Daiichi Sankyo Chemical Pharma Co., Ltd., Iwaki, Japan – FDA Inspections

Source: https://www.keypedia.com/companies/daiichi-sankyo-chemical-pharma-co-ltd/846f1b3f-281e-4616-ae05-902bf9bcb28c

> Inspection records and compliance data for Daiichi Sankyo Chemical Pharma Co., Ltd. in Iwaki. 3 FDA inspections on record, 1 Form 483, last inspected December 22, 2023.

---

## Details

- Name: Daiichi Sankyo Chemical Pharma Co., Ltd.
- FEI Number: 3002808054
- Address Line 1: 389-4, Izumimachi Shimokawa Aza Otsurugi, Izumimachishimogawa
- City: Iwaki
- Country Name: Japan
- Address: 389-4, Izumimachi Shimokawa Aza Otsurugi, Izumimachishimogawa, Iwaki, Japan
- Country: Japan

## Related Documents

- [483 - Daiichi Sankyo Chemical Pharma Co., Ltd. - 2023-12-22](https://www.keypedia.com/records/483/daiichi-sankyo-chemical-pharma-co-ltd/db84195a-9672-4125-97a9-d2d9e88a89b4) — source: FDA, date: December 22, 2023
- [FDA Inspection 1226353 - Daiichi Sankyo Chemical Pharma Co., Ltd. - 2023-12-22](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-chemical-pharma-co-ltd/56a2c626-2e61-41ea-b358-8e6ed18c4d79) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 22, 2023
- [483 - Daiichi Sankyo Chemical Pharma Co., Ltd. - 2021-07-05](https://www.keypedia.com/records/483/daiichi-sankyo-chemical-pharma-co-ltd/ac6f54ee-0044-499f-8449-64de785b9a75) — source: FDA, date: July 5, 2021
- [483 - Daiichi Sankyo Chemical Pharma Co., Ltd. - 2021-04-30](https://www.keypedia.com/records/483/daiichi-sankyo-chemical-pharma-co-ltd/5a115cce-5a93-442d-b935-fee7075e2a6d) — source: FDA, date: April 30, 2021
- [483 - Daiichi Sankyo Chemical Pharma Co., Ltd. - 2019-11-08](https://www.keypedia.com/records/483/daiichi-sankyo-chemical-pharma-co-ltd/0da57ba4-3f2c-4b5d-9103-cf032e02de4a) — source: FDA, date: November 8, 2019
- [FDA Inspection 1080814 - Daiichi Sankyo Chemical Pharma Co., Ltd. - 2019-01-18](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-chemical-pharma-co-ltd/0b7bde6c-6425-4ca6-a6c9-747e82f47a45) — classification: No Action Indicated (NAI), source: FDA, date: January 18, 2019
- FDA Inspection 934436 - Daiichi Sankyo Chemical Pharma Co., Ltd. - 2015-07-02 — classification: No Action Indicated (NAI), source: FDA, date: July 2, 2015

## Related Companies

- [Global Calcium Pvt. Limited](https://www.keypedia.com/companies/global-calcium-pvt-limited/274540f7-e7a4-47fb-b3a0-61fb5e85d807)
- [Biogen International GmbH](https://www.keypedia.com/companies/biogen-international-gmbh/204a24e4-d346-4dc4-b78a-ed40c3085d13)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/ad3c6024-a4cc-403f-86ab-fe86668ef0bc)
- [Shionogi Pharma Co. Ltd.](https://www.keypedia.com/companies/shionogi-pharma-co-ltd/d403b7f0-ba88-4145-a303-36fd7f698ff2)
- [Apitoria Pharma Private Limited](https://www.keypedia.com/companies/apitoria-pharma-private-limited/2159759f-d5e0-45cb-b80a-98f263b7f763)
- [Evive Biopharmaceutical (Beijing), Ltd.](https://www.keypedia.com/companies/evive-biopharmaceutical-beijing-ltd/34316aa6-0386-45be-883d-b7032a5cc0d0)
- [Shandong Anshun Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shandong-anshun-pharmaceutical-co-ltd/875867c5-8c38-42a5-9308-4775215cc951)
- [Biovectra Inc.](https://www.keypedia.com/companies/biovectra-inc/46cb104d-9e11-4208-8344-cc8186412a02)
- [MacroGenics, Inc](https://www.keypedia.com/companies/macrogenics-inc/aaffc8e7-a7dc-4595-a5fb-2e95ee9315d1)
- [Patheon Biologics LLC](https://www.keypedia.com/companies/patheon-biologics-llc/f1012be8-80da-4749-b923-0c97e2b6d47f)

## Related Officers

- [Jun Liu](https://www.keypedia.com/people/jun-liu/39e5d6f3-32fd-426f-880d-3d840a9faed2)
- [Ralph M. Bernstein](https://www.keypedia.com/people/ralph-m-bernstein/72173dfb-24ae-42a1-af9e-1dc7da02ed87)
- [ Investigator, Consumer Safety Officer](https://www.keypedia.com/people/thuy-t-nguyen/1cfb5467-f0b7-49b8-85c1-00373692e35e)
